Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years.

Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years. Abstract Text:

Masaaki Mizui,Junko Tanaka,Keiko Katayama,Toshio Nakanishi,Makoto Obayashi,Shiomi Aimitsu,Tomoo Yoshida,Junichi Inoue,Tatsuji Yokoyama,Keiji Tsuji,Keiko Arataki,Syuji Yamaguchi,Toshio Miura,Mikiya Kitamoto,Eiichi Takezaki,Shigeo Orimen,Tatsurou Sakata,Kouji Kamada,Akira Maruhashi,Tooru Tamura,Toshio Nakamura,Kunio Ishida,Kazushi Teramen,Yuzo Miyakawa,Hiroshi Yoshizawa,

Aim: To portray liver disease and project outcomes in carriers of hepatitis C virus (HCV) in the general population. Methods: Liver disease was evaluated in 1019 individuals who were found with HCV infection at blood donation, and they were followed for 5-10 years with or without receiving interferon (IFN). Results: At baseline, chronic hepatitis was detected in 529 (51.9%) HCV carriers and more frequently in men than in women (62.6% [299/478]vs 42.5% [230/541], P < 0.01); cirrhosis was diagnosed in five (0.5% [three men included]) and hepatocellular carcinoma (HCC) in one (0.1% [man]). Of the carriers who were followed for 5 years or longer, loss of HCV-RNA from serum was achieved in 61 (31.0%) of the 197 treated with interferon (IFN) and only one of the 211 (0.5%) without IFN (P < 0.0001). HCC developed in 14 carriers including six ofthe 211 (2.8%) without IFN and eight of the 197 (4.1%) with IFN (six non-responders included). Follow ups of the 949 carriers identified age (P < 0.002), male gender (P < 0.01) and cirrhosis at the baseline (P < 0.0001) as factors contributing to the development of HCC. Cumulative incidence rates of HCC during 10 years among carriers found with chronic hepatitis increased in parallel with the age at the baseline. Conclusion: Identification of HCV carriers in the general population and treating those indicated with IFN would help decrease the development of HCC and lift its medical, as well as economic, burdens off society.

Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years. Publishing Authors By Initials

M Mizui,J Tanaka,K Katayama,T Nakanishi,M Obayashi,S Aimitsu,T Yoshida,J Inoue,T Yokoyama,K Tsuji,K Arataki,S Yamaguchi,T Miura,M Kitamoto,E Takezaki,S Orimen,T Sakata,K Kamada,A Maruhashi,T Tamura,T Nakamura,K Ishida,K Teramen,Y Miyakawa,H Yoshizawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hepatology research : the official journal of the

VOLUME: 37

Page Numbers: 994-1001

Journal Abbreviation: Hepatol. Res.

ISSN: 1386-6346

DAY: 11

MONTH: 07

YEAR: 2007

Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9711801

Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years.

AFFILIATION: Department of Laboratory Medicine, Japanese Red Cross, Hiroshima Blood Center, Hiroshima, Japan.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hepatol Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years Related Publications

• Absorption spectral properties of purified halorhodopsin.
• Asymmetric synthesis and stereochemical structure-activity relationship of (R)- and (S)-8-[1-(2,4-dichlorophenyl)-2-imidazol-1-yl-ethoxy] octanoic acid heptyl ester, a potent inhibitor of allene oxide synthase.
• Cervical cord compression due to extradural granulation tissue in rheumatoid arthritis. A review of five cases.
• Computational mutation analysis of hydrogen abstraction and radical rearrangement steps in the catalysis of coenzyme B12-dependent diol dehydratase.
• Construction of monoenergetic neutron calibration fields using 45Sc(p, n)45Ti reaction at JAEA.
• Detection and quantification of calcifications in intravascular ultrasound images by automatic thresholding.
• Detection of cyclic GMP binding protein and ion channel activity in frog rod outer segments.
• Energetic feasibility of hydrogen abstraction and recombination in coenzyme B(12)-dependent diol dehydratase reaction.
• Formation of 7-cis retinal by the direct irradiation of all-trans retinal.
• Fractal dimension of 40MHz intravascular ultrasound radio frequency signals.
• Generation of anti-tumour effector T cells from naïve T cells by stimulation with dendritic/tumour fusion cells.
• How heme metabolism occurs in heme oxygenase: computational study of oxygen-donation ability of the oxo and hydroperoxo species.
• Imaging of cauda equina edema in lumbar canal stenosis by using gadolinium-enhanced MR imaging: experimental constriction injury.
• Immunoprophylaxis of perinatal infection with hepatitis B virus on the national scale.
• Isolation and characterization of simple sequence repeat markers in the hexaploid forage grass timothy (Phleum pratense L.).
• Isomeric composition of retinal chromophore in dark-adapted bacteriorhodopsin.
• Light-induced reaction of halorhodopsin prepared under low salt conditions.
• Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years.
• Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C.
• Molecular switch in tandem winged-helix motifs of elongation factor SelB.
• Proceedings: The photoreceptive mechanism in vision.
• Substitution of the use of radioactivity by fluorescence for biochemical studies of RNA.
• Three-dimensional spectral map of atrial fibrillation by a 64-channel magnetocardiogram.
• [A case of adrenal tuberculosis complicated with acute exacerbation of adrenal insufficiency during the initial phase of anti-tuberculosis therapy for pulmonary tuberculosis]
• [Allergic lung diseases]
• [Clinical instruction to be given to nursing students assigned to a patient with liver cirrhosis (2)]
• [Cooperation between enzyme science and theoretical chemistry for a new paradigm in enzyme research]
• [Similarities between chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.]
• [The current educational status and the future problems concerning radiotherapy in nursing education--a nationwide survey at nursing and practical nursing educational facilities]
• [The level of understanding by clinical nurses on the subject of radiation protection and future problems in nursing education--analysis of the results of a survey among radiology technologists]